F11.20

Opioid dependence, uncomplicated

Opioid dependence, uncomplicated, is a chronic, relapsing medical condition characterized by a cluster of cognitive, behavioral, and physiological symptoms indicating that the individual continues using opioids despite significant substance-related problems. This diagnosis is part of a spectrum of opioid use disorders and specifically denotes the presence of dependence—often involving tolerance and withdrawal—without current acute complications such as opioid-induced delirium, mood disorders, or psychotic manifestations. Pathophysiologically, it involves neuroadaptive changes in the brain's reward and stress circuits, particularly the mu-opioid receptors and the mesolimbic dopamine system. The 'uncomplicated' status implies the clinical focus is on the core addictive behavior and physiological dependence itself, rather than an immediate secondary psychiatric or acute physiological crisis induced by the drug.

Clinical Symptoms

Compulsive craving or a strong desire to use opioids
Tolerance, defined by a need for markedly increased amounts to achieve intoxication
Diminished effect with continued use of the same amount of the substance
Inability to control or reduce opioid consumption despite the desire to do so
Spending a great deal of time in activities necessary to obtain, use, or recover from opioids
Recurrent opioid use resulting in a failure to fulfill major role obligations at work, school, or home
Continued opioid use despite having persistent or recurrent social or interpersonal problems
Giving up or reducing important social, occupational, or recreational activities because of opioid use
Recurrent opioid use in situations in which it is physically hazardous
Continued opioid use despite knowledge of having a persistent physical or psychological problem likely caused by the substance

Common Causes

Neurobiological changes in the brain's reward system following repeated exposure to exogenous opioids
Prolonged use of prescription opioid analgesics for chronic pain management
Genetic predisposition and heritable traits associated with substance use disorders
History of adverse childhood experiences (ACEs) or significant psychological trauma
Co-morbid psychiatric conditions such as major depressive disorder, anxiety disorders, or PTSD
Environmental factors including high availability of opioids and peer group influences
Early age of first opioid use or experimentation
Socioeconomic stressors and lack of supportive community or family structures

Documentation & Coding Tips

Distinguish between dependence and non-dependent use or long term use for pain management.

Example: Patient presents for medication management of opioid dependence, uncomplicated (F11.20). History includes 10 years of intravenous heroin use. Patient reports tolerance and a inability to cut down use despite social consequences. No current intoxication or withdrawal symptoms. The diagnosis of opioid dependence is a chronic condition that contributes to the complexity of the patient care plan and maps to HCC 55.

Billing Focus: Documentation must specify dependence rather than abuse or simple use to support the F11.2 series. Clearly state the lack of current intoxication or withdrawal to justify the F11.20 uncomplicated code.

Identify the specific type of opioid agent to ensure precise code assignment even if the manifestation is uncomplicated.

Example: Subjective: 34-year-old male with chronic back pain originally treated with prescription oxycodone, now utilizing illicitly obtained fentanyl. Objective: Patient meets DSM-5 criteria for severe opioid use disorder, currently uncomplicated (F11.20). Assessment: Opioid dependence, uncomplicated. Plan: Transition to Buprenorphine/Naloxone. Note inclusion of prescription to illicit transition for medical necessity of MAT.

Billing Focus: Identify if the opioid is prescription, illicit, or both to clarify the medical necessity of the treatment interventions provided.

Explicitly document the absence of associated mental health or physical complications to support the uncomplicated status.

Example: Diagnosis: Opioid dependence, uncomplicated (F11.20). Patient is currently stable on methadone maintenance therapy. Review of systems is negative for opioid-induced mood disorder, sleep disorder, or sexual dysfunction. Physical exam reveals no signs of acute overdose or withdrawal. Patient is maintained in a stable state for this chronic condition.

Billing Focus: The code F11.20 specifically excludes cases with intoxication (F11.22), withdrawal (F11.23), or induced psychotic disorders (F11.25). Documenting the absence of these manifestations validates the .20 extension.

Document the status of remission clearly when the patient is no longer actively using but requires ongoing monitoring.

Example: Patient with a history of heroin dependence, currently in sustained remission for 14 months, presents for follow-up. Clinical assessment confirms Opioid dependence in remission (F11.21). No cravings or lapses reported. Continues on Naltrexone for relapse prevention. Remission status is documented to differentiate from active, uncomplicated dependence (F11.20).

Billing Focus: Remission status (F11.21) is a distinct clinical state from F11.20. Correct coding depends on the duration and clinical stability of the patient.

Link opioid dependence to other co-occurring chronic conditions or complications such as infectious diseases.

Example: Assessment: Opioid dependence, uncomplicated (F11.20) and Chronic Hepatitis C (B18.2) without mention of hepatic coma. The patient history of injection drug use is the primary risk factor for the viral hepatitis. Plan: Refer to GI for Hep C staging while continuing substance use counseling.

Billing Focus: Establishing the relationship between the substance use and other medical conditions supports higher level E/M coding based on the complexity of managing multiple interacting chronic conditions.

Relevant CPT Codes

99213 - Office or other outpatient visit for the evaluation and management of an established patient, which requires a professionally recognized low level of medical decision making
Used for routine follow-up of stable patients on maintenance therapy where the complexity is low.
99214 - Office or other outpatient visit for the evaluation and management of an established patient, which requires a professionally recognized moderate level of medical decision making
Applied when managing dependence with comorbidities or adjusting MAT dosages requiring moderate complexity.
99215 - Office or other outpatient visit for the evaluation and management of an established patient, which requires a professionally recognized high level of medical decision making
Necessary for patients with severe comorbid psychiatric conditions or life-threatening medical issues linked to their dependence.
99204 - Office or other outpatient visit for the evaluation and management of a new patient, which requires a professionally recognized moderate level of medical decision making
Typical for a new patient intake and initial diagnosis of opioid dependence with treatment planning.
G2211 - Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services
Reflects the ongoing, longitudinal relationship required to manage a chronic condition like opioid dependence.
80305 - Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; capable of being read by direct optical observation only
Routine monitoring of compliance and detection of other substances in patients with opioid dependence.
99408 - Alcohol and/or substance (other than tobacco) abuse structured screening and brief intervention (SBI) services; 15 to 30 minutes
Used for screening and initial intervention sessions for patients identified with substance use issues.
90833 - Psychotherapy, 30 minutes with patient when performed with an evaluation and management service
Used when the provider provides dedicated therapy for dependence alongside a medical E/M visit.
H0001 - Alcohol and/or drug assessment
Specifically for comprehensive substance use disorder evaluations in specialized clinics.
G0396 - Alcohol and/or substance (other than tobacco) misuse structured screening and brief intervention services; 15 to 30 minutes
Medicare specific code for screening and intervention services in the primary care setting.